title: Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines.
abstract: Hematopoietic cells are attractive targets for gene therapy. However, no satisfactory vectors are currently available. A major problem with the most commonly used adenovirus vectors, based on adenovirus type 2 (Ad2) or Ad5, is their low binding efficiency for hematopoietic cells. In this study we identify two adenovirus serotypes with high affinity for hematopoietic cells. The binding efficiency of prototype serotypes Ad4p, Ad11p, and Ad35p for different committed hematopoietic cell lines representing T cells (Jurkat), B cells (DG75), monocytes (U937-2), myeloblasts (K562), and granulocytes (HL-60) was evaluated and compared to that of Ad5v, the commonly used adenovirus vector, using flow cytometry. In contrast to Ad5v, which bound to less than 10% of the cells in all experiments, Ad11p and Ad35p showed high binding efficiency for all of the different hematopoietic cell lines. Ad4p bound to the lymphocytic cell lines to some extent but less well to the myelomonocytic cell lines. The abilities of the different serotypes to infect, replicate, and form complete infectious particles in the hematopoietic cell lines were also investigated by immunostaining, (35)S labeling of viral proteins, and titrations of cell lysates. Ad11p and Ad35p infected the highest proportion of cells, and Ad11p infected all of the cell lines investigated. The Ad11p hexon was expressed equally well in K562 and A549 cells. Jurkat cells also showed high levels of expression of Ad11p hexons, but the production of infectious particles was low. The binding properties of virions were correlated to their ability to infect and be expressed.
authors.affiliation: Department of Virology, Umeå University, 901 85 Umeå, Sweden. Anna.Segerman@climi.umu.se
authors.forename: A
authors.initials: A
authors.lastname: Segerman
authors.forename: Y F
authors.initials: YF
authors.lastname: Mei
authors.forename: G
authors.initials: G
authors.lastname: Wadell
mesh_terms: D000260:Adenoviruses, Human / Q000145:classification / Q000472:pathogenicity / Q000502:physiology*; D001402:B-Lymphocytes / Q000821:virology; D002460:Cell Line; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006098:Granulocytes / Q000821:virology; D018922:HL-60 Cells; D006801:Humans; D019169:Jurkat Cells; D020014:K562 Cells; D007962:Leukocytes / Q000821:virology*; D009000:Monocytes / Q000821:virology; D011991:Receptors, Virus / Q000378:metabolism; D012703:Serotyping; D013601:T-Lymphocytes / Q000821:virology; D020298:U937 Cells; D015678:Viral Structural Proteins / Q000378:metabolism; D014771:Virion / Q000502:physiology; D014779:Virus Replication
chemical_list: D011991:Receptors, Virus; D015678:Viral Structural Proteins